Natera (NTRA) News Today $151.15 +1.52 (+1.02%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$154.05 +2.90 (+1.92%) As of 03/21/2025 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Thrivent Financial for Lutherans Reduces Stock Holdings in Natera, Inc. (NASDAQ:NTRA)Thrivent Financial for Lutherans lessened its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 19.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 115,965 shares of the medical research company's stock after selMarch 23 at 4:18 AM | marketbeat.comEnvestnet Portfolio Solutions Inc. Trims Stock Position in Natera, Inc. (NASDAQ:NTRA)Envestnet Portfolio Solutions Inc. decreased its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 20.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,416 shares of the medical research company's stock after selling 2,March 23 at 4:00 AM | marketbeat.comSemanteon Capital Management LP Boosts Stock Holdings in Natera, Inc. (NASDAQ:NTRA)Semanteon Capital Management LP boosted its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 25.6% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,027 shares of the medical research company's stock after acquiring an additiMarch 22 at 6:04 AM | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by Harvest Fund Management Co. LtdHarvest Fund Management Co. Ltd lessened its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 33.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,205 shares of the medical research companMarch 22 at 5:02 AM | marketbeat.comAvantax Advisory Services Inc. Cuts Stake in Natera, Inc. (NASDAQ:NTRA)Avantax Advisory Services Inc. reduced its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 30.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,635 shares of the medical research companMarch 21 at 3:52 AM | marketbeat.comMichael Burkes Brophy Sells 792 Shares of Natera, Inc. (NASDAQ:NTRA) StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 792 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $146.04, for a total transaction of $115,663.68. Following the sale, the chief financial officer now directly owns 71,869 shares in the company, valued at $10,495,748.76. This trade represents a 1.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.March 20 at 10:29 PM | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Insider Sells $149,837.04 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) insider Solomon Moshkevich sold 1,026 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $146.04, for a total transaction of $149,837.04. Following the completion of the sale, the insider now directly owns 144,782 shares of the company's stock, valued at $21,143,963.28. This represents a 0.70 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.March 20 at 10:29 PM | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CEO Sells $978,693.06 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CEO Steven Leonard Chapman sold 6,702 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $146.03, for a total transaction of $978,693.06. Following the completion of the transaction, the chief executive officer now directly owns 203,354 shares in the company, valued at approximately $29,695,784.62. This represents a 3.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.March 20 at 10:29 PM | marketbeat.comNatera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology PackMarch 20 at 1:34 PM | theglobeandmail.comHere’s What Lifted Natera (NTRA) in Q4 and 2024March 20 at 8:34 AM | msn.comInsider Selling: Natera, Inc. (NASDAQ:NTRA) CFO Sells 792 Shares of StockMarch 20 at 7:26 AM | insidertrades.comNatera (NASDAQ:NTRA) Upgraded to "Hold" at StockNews.comMarch 20 at 4:08 AM | americanbankingnews.comHere Are Billionaire Stanley Druckenmiller's 5 Biggest Stock HoldingsMarch 19, 2025 | fool.comNatera (NASDAQ:NTRA) Upgraded at StockNews.comStockNews.com raised shares of Natera from a "sell" rating to a "hold" rating in a research note on Wednesday.March 19, 2025 | marketbeat.comNatera: Strong Growth Trajectory Despite Stretched Valuation MetricsMarch 18, 2025 | seekingalpha.comIs Natera (NTRA) the Best Biotech Stock According to Billionaires?March 18, 2025 | msn.comNikko Asset Management Americas Inc. Increases Stock Position in Natera, Inc. (NASDAQ:NTRA)Nikko Asset Management Americas Inc. boosted its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 10.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 740,837 shares of the medical reseaMarch 18, 2025 | marketbeat.comIs Natera, Inc. (NTRA) a Best Biotech Stock According to Billionaires?March 17, 2025 | insidermonkey.comNatera: Growth Looks Unstoppable, Positive EPS Just A Matter Of TimeMarch 17, 2025 | seekingalpha.comNatera: Solid Execution, Pricey StockMarch 17, 2025 | seekingalpha.comSwiss National Bank Purchases 4,900 Shares of Natera, Inc. (NASDAQ:NTRA)Swiss National Bank increased its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 2.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 232,800 shares of the medical research company's stock after buying aMarch 17, 2025 | marketbeat.comBrokerages Set Natera, Inc. (NASDAQ:NTRA) PT at $178.12March 17, 2025 | americanbankingnews.comCatalyst Funds Management Pty Ltd Buys 12,025 Shares of Natera, Inc. (NASDAQ:NTRA)Catalyst Funds Management Pty Ltd grew its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 179.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 18,725 shares of the medical research company's stock after acquiring an additMarch 16, 2025 | marketbeat.comPoinciana Advisors Group LLC Invests $279,000 in Natera, Inc. (NASDAQ:NTRA)Poinciana Advisors Group LLC purchased a new position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,763 shares of the medical research companMarch 16, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Stock Position Cut by Picton Mahoney Asset ManagementPicton Mahoney Asset Management trimmed its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 2.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 95,390 shares of the medical research company's stock after selling 2,4March 16, 2025 | marketbeat.comNatera (NASDAQ:NTRA) Stock Rating Upgraded by Royal Bank of CanadaRoyal Bank of Canada upgraded shares of Natera to a "moderate buy" rating in a research report on Wednesday.March 16, 2025 | marketbeat.comErste Asset Management GmbH Invests $2.24 Million in Natera, Inc. (NASDAQ:NTRA)Erste Asset Management GmbH acquired a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 14,000 shares of the medical research company's stock, valued aMarch 16, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by Skandinaviska Enskilda Banken AB publSkandinaviska Enskilda Banken AB publ decreased its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 73.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 38,799 shares of the medical researcMarch 16, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Trims Stock Position in Natera, Inc. (NASDAQ:NTRA)Connor Clark & Lunn Investment Management Ltd. cut its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 16.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 60,365 shares of the medical research comMarch 16, 2025 | marketbeat.comNatera (NASDAQ:NTRA) Now Covered by Royal Bank of CanadaMarch 16, 2025 | americanbankingnews.comInsider Selling: Natera, Inc. (NASDAQ:NTRA) Director Sells 4,000 Shares of StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) Director Gail Boxer Marcus sold 4,000 shares of Natera stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average price of $147.69, for a total value of $590,760.00. Following the transaction, the director now directly owns 9,704 shares in the company, valued at approximately $1,433,183.76. The trade was a 29.19 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.March 15, 2025 | marketbeat.comStock Traders Buy High Volume of Put Options on Natera (NASDAQ:NTRA)Natera, Inc. (NASDAQ:NTRA - Get Free Report) saw unusually large options trading activity on Friday. Investors acquired 7,482 put options on the company. This represents an increase of 450% compared to the average daily volume of 1,360 put options.March 15, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Acquired by Zurcher Kantonalbank Zurich CantonalbankZurcher Kantonalbank Zurich Cantonalbank boosted its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 14.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 30,231 shares of the medical research company's stock aMarch 15, 2025 | marketbeat.comProficio Capital Partners LLC Invests $16.11 Million in Natera, Inc. (NASDAQ:NTRA)Proficio Capital Partners LLC purchased a new stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 101,787 shares of the medMarch 15, 2025 | marketbeat.comRBC Capital Initiates Coverage of Natera (NTRA) with Outperform RecommendationMarch 14, 2025 | msn.comRoyal Bank of Canada Begins Coverage on Natera (NASDAQ:NTRA)Royal Bank of Canada assumed coverage on Natera in a report on Thursday. They set an "outperform" rating and a $251.00 price target on the stock.March 14, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of "Buy" by BrokeragesShares of Natera, Inc. (NASDAQ:NTRA - Get Free Report) have earned a consensus rating of "Buy" from the seventeen brokerages that are currently covering the company, Marketbeat.com reports. Seventeen analysts have rated the stock with a buy rating. The average 12-month price objective among brokerMarch 14, 2025 | marketbeat.comNatera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to BoardMarch 13, 2025 | finance.yahoo.comKing Luther Capital Management Corp Sells 14,560 Shares of Natera, Inc. (NASDAQ:NTRA)King Luther Capital Management Corp reduced its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 48.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 15,476 shares of the medical research company's stock after sMarch 13, 2025 | marketbeat.comNatera initiated with an Outperform at RBC CapitalMarch 12, 2025 | msn.comAGF Management Ltd. Sells 557,463 Shares of Natera, Inc. (NASDAQ:NTRA)AGF Management Ltd. cut its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 82.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 116,091 shares of the medical research company's stock after selling 557,463 shares during theMarch 12, 2025 | marketbeat.comAmundi Lowers Stake in Natera, Inc. (NASDAQ:NTRA)Amundi reduced its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 8.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 433,186 shares of the medical research company's stock after selling 40,930 shares duringMarch 12, 2025 | marketbeat.comWhy Is Natera (NTRA) Stock Soaring TodayMarch 11, 2025 | msn.comAssetmark Inc. Purchases 3,801 Shares of Natera, Inc. (NASDAQ:NTRA)Assetmark Inc. raised its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 51.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 11,154 shares of the medical research company's stock after buying an additional 3,801 shares during the period. AsMarch 11, 2025 | marketbeat.comNatera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast CancerMarch 10, 2025 | finance.yahoo.comNatera, Inc. (NASDAQ:NTRA) Stock Holdings Increased by Jones Financial Companies LllpJones Financial Companies Lllp boosted its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 4,257.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,878 shares of the medical research company's stMarch 10, 2025 | marketbeat.comAigen Investment Management LP Buys New Shares in Natera, Inc. (NASDAQ:NTRA)Aigen Investment Management LP bought a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 1,805 shares of the medical research company's stock, valued at approximately $286,March 9, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Insider Sells $859,740.00 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) insider Solomon Moshkevich sold 6,000 shares of the firm's stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $143.29, for a total value of $859,740.00. Following the completion of the sale, the insider now directly owns 143,768 shares of the company's stock, valued at $20,600,516.72. This represents a 4.01 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.March 9, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CEO Sells $12,514,804.80 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CEO Steven Leonard Chapman sold 87,272 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $143.40, for a total transaction of $12,514,804.80. Following the sale, the chief executive officer now directly owns 203,354 shares of the company's stock, valued at approximately $29,160,963.60. This trade represents a 30.03 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.March 9, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Insider Sells $859,740.00 in StockMarch 8, 2025 | insidertrades.com Remove Ads Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address NTRA Media Mentions By Week NTRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTRA News Sentiment▼0.940.64▲Average Medical News Sentiment NTRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTRA Articles This Week▼2511▲NTRA Articles Average Week Remove Ads Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FMS News Today HIMS News Today OPCH News Today GH News Today RDNT News Today SHC News Today SGRY News Today BTSG News Today PRVA News Today WGS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTRA) was last updated on 3/23/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.